Abstract: An engineered transcriptional modulator (ETM) comprising: (a) at least one epigenetic effector domain; operably linked to (b) an endonuclease.
Type:
Application
Filed:
February 1, 2022
Publication date:
May 2, 2024
Applicant:
EPSILEN BIO S.R.L
Inventors:
Angelo Leone Lombardo, Alice Reschigna, Tania Baccega